Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To assess the major (complete/partial) cytogenetic response (MCyR) rate
Critère d'inclusion
- Adult patients with chronic phase Ph+ CML whose disease is resistant following treatment with at least two BCR-ABL tyrosine kinase inhibitors (i.e. imitinib, nilotinib, or dasatinib)